[ET Net News Agency, 31 March 2025] HANSOH PHARMA (03692) rose 3.8% to HK$24.5.
It hits an intra-day high of HK$24.5, hitting a 52-week high, and an intra-day low of
HK$23.35. The total shares traded was 2.36 million, with a value of HK$56.25m. The active
buy/sell ratio is 68:32, with net buying turnover of HK$15m. CHINA INNOVATION MARKET SER
accounts for greatest net responsive buying turnover of HK$717,797, with volume weighted
average price of HK$24.045. J.P. MORGAN BRO (HK) accounts for greatest net responsive
selling turnover of HK$5.31m, with volume weighted average price of HK$24.069. The stock
has risen a combined 16.7% over the past 3 consecutive trading days.
The Hang Seng Index now fell 174 points, or 0.7% to 23,251.

Basic Information
=================

---------------------------------
Nominal 24.500 % Chg +3.81%
High 24.500 Low 23.350
Shares Tr 2.36m Turnover 56.25m
10-D SMA 21.485 %H.V 49.978
20-D SMA 20.176 VWAP 23.885
50-D SMA 18.858 RSI14 77.510
---------------------------------
Status: Hitting a 52-week high, active buy/sell ratio is 68:32, with net buying turnover
of HK$15m, rising a combined 16.7% over the past 3 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HANSOH PHARMA (03692) 24.50 +3.81
SIHUAN PHARM (00460) 0.59 -1.67
GRAND PHARMA (00512) 6.28 +0.16
SINO BIOPHARM (01177) 3.74 +0.27
LIVZON PHARMA (01513) 27.05 -1.10
LUYE PHARMA (02186) 2.24 -9.68
FOSUN PHARMA (02196) 15.30 -0.91
SH PHARMA (02607) 11.20 -0.53
CHINARES PHARMA (03320) 5.17 -0.96
GOLDEN THROAT (06896) 4.27 +7.56
-----------------------------------------------
(ed)